CSIMarket


Merck and Co Inc   (MRK)
Other Ticker:  
 

Merck and Co Inc

MRK's Fundamental analysis








Looking into Merck And Co Inc growth rates, revenue grew by 31.63 % in I. Quarter 2022 from the same quarter a year ago. Ranking at No. 403

Major Pharmaceutical Preparations industry recorded growth of revenues by 19.44 %

Merck And Co Inc 's net income grew by 35.37 % in I. Quarter 2022 year on year, above company average,

More on MRK's Growth


Merck And Co Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Merck And Co Inc PEG ratio is at 0.16 Company is currently trading with Price to Cash flow multiple of 147.96 in trailing twelve-month period.
Company
16.74
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.52.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.37.


More on MRK's Valuation
 
 Total Debt (Millions $) 31,794
 Dividend TTM ($) 2.65 $
 Dividend Yield TTM (%) 2.94 %
 Revenue/Employee (TTM) $ 739,789
 Net Income/Employee (TTM) $ 199,845
 Receivable Turnover (TTM) 5.92
 Tangible Book Value (Per Share $) -1.31

Merck And Co Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Merck And Co Inc PEG ratio is at 0.16 Company is currently trading with Price to Cash flow multiple of 147.96 in trailing twelve-month period.
Company
16.74
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.52.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.37.

Merck And Co Inc Price to Book Ratio is at 5.79 lower than Indusry Avg. of 1282.42. and higher than S&P 500 Avg. of -0.01

More on MRK's Valuation

  Market Capitalization (Millions $) 237,177
  Shares Outstanding (Millions) 2,535
  Employees 71,000
  Revenues (TTM) (Millions $) 52,525
  Net Income (TTM) (Millions $) 14,189
  Cash Flow (TTM) (Millions $) 1,603
  Capital Exp. (TTM) (Millions $) -4,298
  Total Debt (Millions $) 31,794
  Dividend TTM ($) 2.65 $
  Dividend Yield TTM (%) 2.94 %
  Revenue/Employee (TTM) $ 739,789
  Net Income/Employee(TTM) $ 199,845
  Receivable Turnover Ratio (TTM) 5.92
  Tangible Book Value (Per Share $) -1.31

  Market Capitalization (Millions $) 237,177
  Shares Outstanding (Millions) 2,535
  Employees 71,000
  Revenues (TTM) (Millions $) 52,525
  Net Income (TTM) (Millions $) 14,189
  Cash Flow (TTM) (Millions $) 1,603
  Capital Exp. (TTM) (Millions $) -4,298


    MRK's Profitability Comparisons
Merck And Co Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in I. Quarter 2022 to 35.02 % from 25.64 % in IV. Quarter.

Merck And Co Inc net profit margin of 27.12 % is currently ranking no. 18 in Major Pharmaceutical Preparations industry, ranking no. 41 in Healthcare sector and number 638 in S&P 500.


Profitability by Segment
Merck Pharmaceutical 63.2 %



  Ratio
   Capital Ratio (MRQ) 1.4
  Total Debt to Equity (MRQ) 0.78
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.53
  Inventory Turnover Ratio (TTM) 2.69



Merck And Co Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in I. Quarter 2022 to 35.02 % from 25.64 % in IV. Quarter.

Merck And Co Inc net profit margin of 27.12 % is currently ranking no. 18 in Major Pharmaceutical Preparations industry, ranking no. 41 in Healthcare sector and number 638 in S&P 500.

More on MRK's Key Ratios



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ACRO's Profile

Stock Price

ACRO's Financials

Business Description

Fundamentals

Charts & Quotes

ACRO's News

Suppliers

ACRO's Competitors

Customers & Markets

Economic Indicators

ACRO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071